Apr 4, 2022 08:30AM Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference

Mar 30, 2022 02:58PM Needham & Company Reiterates Zealand Pharma (ZEAL) at Buy with $42 PT, Views New Strategy and CEO Appointment Positively

Mar 10, 2022 04:38PM Needham & Company Reiterates Zealand Pharma (ZEAL) at Buy, Short Bowel Syndrome Program Remains Main Value Driver

Mar 25, 2021 04:05PM Zealand Pharma to participate in upcoming investor conferences

Mar 25, 2021 04:05PM Zealand Pharma to participate in upcoming investor conferences

Jul 9, 2020 08:06AM Companies with NDRs 7/09

Jun 17, 2020 11:26AM Zealand Pharma (ZEAL) announces directed issues and private placements of up to approx. 2.68 million new ordinary shares

Jun 17, 2020 11:25AM Zealand Pharma announces directed issues and private placements of up to approx. 2.68 million new ordinary shares

Mar 26, 2020 06:45AM Companies with NDRs 3/26

Nov 15, 2019 08:26AM Zealand Pharma A/S (ZEAL) PT Raised to $42 at Needham & Company

Sep 16, 2019 08:06AM Companies with NDRs 09/16

Aug 15, 2019 03:59PM Zealand Pharma A/S (ZEAL) PT Raised to $32 at Needham & Company

Apr 2, 2019 07:00AM Zealand Pharma to attend Needham Healthcare Conference

Sep 18, 2018 05:03PM Zealand Pharma A/S (ZEAL) PT Raised to $29 at Needham & Company

Mar 22, 2018 04:17AM Zealand Pharma to present at the Needham Healthcare Conference, March 27, 2018 in New York

Sep 5, 2017 06:39AM Needham & Company Starts Zealand Pharma A/S (ZEAL) at Buy

Aug 18, 2017 04:04AM Completion of exercise in full of overallotment option of 15%

Aug 15, 2017 09:21AM Overallotment option of 15% has been exercised

Aug 15, 2017 09:18AM End of stabilization period

Aug 14, 2017 03:31AM Completion of the initial public offering of American Depositary Shares and registration of capital increase

Aug 9, 2017 10:15AM Zealand Pharma (ZEAL) IPO Opens Modestly Higher

Aug 1, 2017 04:43PM Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States